Giuseppe Ciaramella

CIK: 0001786322

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (29.4%)

Position reduction

Option Exercises (M)7 (41.2%)

Derivative conversions

Awards (A)4 (23.5%)

Compensation grants

Other (G, F, J, C, D, …)1 (5.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BEAM

Beam Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (17 total)

BEAM
Beam Therapeutics Inc.
Sep 24, 2026
Gift(G)
Direct
123.4K shares-
BEAM
Beam Therapeutics Inc.
Jun 17, 2026
Exercise(M)
Direct
29K shares at avg. $1.03$30K
BEAM
Beam Therapeutics Inc.
Jun 17, 2026
Exercise(M)
Direct
6.5K shares at avg. $0.67$4K
BEAM
Beam Therapeutics Inc.
Apr 1, 2026
Sale(S)
Direct
11.8K shares at avg. $24.58$290K
BEAM
Beam Therapeutics Inc.
Mar 31, 2026
Award(A)
Direct
40K shares-
BEAM
Beam Therapeutics Inc.
Feb 24, 2026
Sale(S)
Direct
35K shares at avg. $32.00$1.1M
BEAM
Beam Therapeutics Inc.
Feb 24, 2026
Exercise(M)
Direct
35K shares at avg. $17.00$595K
BEAM
Beam Therapeutics Inc.
Jan 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
80K shares-
BEAM
Beam Therapeutics Inc.
Apr 1, 2025
Sale(S)
Direct
7.4K shares at avg. $18.35$136K
BEAM
Beam Therapeutics Inc.
Mar 31, 2025
Award(A)
Direct
35K shares-
BEAM
Beam Therapeutics Inc.
Jan 31, 2025
Award(A)
Stock Option (Right to Buy)
Direct
70K shares-
BEAM
Beam Therapeutics Inc.
Dec 17, 2024
Exercise(M)
Direct
53.5K shares at avg. $0.67$36K
BEAM
Beam Therapeutics Inc.
Nov 6, 2024
Sale(S)
Direct
51.1K shares at avg. $26.36$1.3M
BEAM
Beam Therapeutics Inc.
Oct 14, 2024
Exercise(M)
Direct
1.5K shares at avg. $7.22$11K
BEAM
Beam Therapeutics Inc.
Oct 14, 2024
Exercise(M)
Direct
13K shares at avg. $4.22$55K
BEAM
Beam Therapeutics Inc.
Oct 14, 2024
Sale(S)
Direct
51.1K shares at avg. $26.27$1.3M
BEAM
Beam Therapeutics Inc.
Oct 14, 2024
Exercise(M)
Direct
27.3K shares at avg. $0.67$18K

		Type	Shares	Price		Ownership
Sep 24, 2026	BEAM Beam Therapeutics Inc.	Gift(G)	123,407	-	$0	Direct
Jun 17, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	29,000	$1.03	$29,870	Direct
Jun 17, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	6,505	$0.67	$4,358	Direct
Apr 1, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	11,810	$24.58	$290,290	Direct
Mar 31, 2026	BEAM Beam Therapeutics Inc.	Award(A)	40,000	-	$0	Direct
Feb 24, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	35,000	$32.00	$1,120,042	Direct
Feb 24, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	35,000	$17.00	$595,000	Direct
Jan 31, 2026	BEAM Beam Therapeutics Inc.	Award(A) Stock Option (Right to Buy)	80,000	-	-	Direct
Apr 1, 2025	BEAM Beam Therapeutics Inc.	Sale(S)	7,434	$18.35	$136,418	Direct
Mar 31, 2025	BEAM Beam Therapeutics Inc.	Award(A)	35,000	-	-	Direct
Jan 31, 2025	BEAM Beam Therapeutics Inc.	Award(A) Stock Option (Right to Buy)	70,000	-	-	Direct
Dec 17, 2024	BEAM Beam Therapeutics Inc.	Exercise(M)	53,500	$0.67	$35,845	Direct
Nov 6, 2024	BEAM Beam Therapeutics Inc.	Sale(S)	51,110	$26.36	$1,347,050	Direct
Oct 14, 2024	BEAM Beam Therapeutics Inc.	Exercise(M)	1,457	$7.22	$10,520	Direct
Oct 14, 2024	BEAM Beam Therapeutics Inc.	Exercise(M)	12,979	$4.22	$54,771	Direct
Oct 14, 2024	BEAM Beam Therapeutics Inc.	Sale(S)	51,110	$26.27	$1,342,752	Direct
Oct 14, 2024	BEAM Beam Therapeutics Inc.	Exercise(M)	27,318	$0.67	$18,303	Direct

1-17 of 17 transactions

About Ciaramella Giuseppe

Ciaramella Giuseppe (SEC CIK 0001786322) files insider reports with the SEC as President of Beam Therapeutics Inc. (BEAM).

Signal8 holds 12 ownership filings by Ciaramella Giuseppe, all Form 4s, filed between Oct 16, 2024 and Sep 25, 2026. Those filings report 17 transactions, from Oct 14, 2024 to Sep 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ciaramella Giuseppe's filings is in CAMBRIDGE, MA.

Recent filings by Ciaramella Giuseppe

Sep 24, 2026: Gift of BEAM shares (Form 4, code G).
Jun 17, 2026: Option exercises of BEAM shares (2 lines, Form 4, code M).
Apr 1, 2026: Open-market sale of BEAM shares (Form 4, code S).
Mar 31, 2026: Grant or award of BEAM shares (Form 4, code A).
Feb 24, 2026: Open-market sale of BEAM shares (Form 4, code S).

Other insiders filing for Beam Therapeutics Inc. (BEAM)

Evans John M., CEO
Cavanagh Bethany J, SVP, Finance and Treasurer
Simon Amy, Chief Medical Officer
FMR LLC, 10% Owner
Shaw Christi, Director
Walsh Kathleen E, Director

How to read Form 4 transaction codes